News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
690,995 Results
Type
Article (60321)
Company Profile (100)
Press Release (630574)
Section
Business (197756)
Career Advice (2983)
Deals (34573)
Drug Delivery (96)
Drug Development (80755)
Employer Resources (169)
FDA (15947)
Job Trends (14996)
News (338243)
Policy (32511)
Tag
Academia (2796)
Alliances (49429)
Alzheimer's disease (1244)
Approvals (15878)
Artificial intelligence (142)
Bankruptcy (305)
Best Places to Work (11509)
Breast cancer (123)
Cancer (1109)
Cardiovascular disease (96)
Career advice (2521)
Cell therapy (257)
Clinical research (63955)
Collaboration (393)
Compensation (135)
COVID-19 (2608)
C-suite (105)
Data (1129)
Diabetes (149)
Diagnostics (6198)
Drug pricing (88)
Earnings (74383)
Employer resources (149)
Events (104416)
Executive appointments (326)
FDA (16502)
Funding (353)
Gene therapy (186)
GLP-1 (603)
Government (4673)
Healthcare (18989)
Infectious disease (2689)
Inflammatory bowel disease (112)
Interviews (567)
IPO (15622)
Job creations (3844)
Job search strategy (2114)
Layoffs (465)
Legal (7745)
Lung cancer (174)
Manufacturing (177)
Medical device (13072)
Medtech (13077)
Mergers & acquisitions (19066)
Metabolic disorders (408)
Neuroscience (1515)
NextGen Class of 2024 (6759)
Non-profit (4653)
Northern California (1396)
Obesity (231)
Opinion (228)
Patents (107)
People (59585)
Phase I (19894)
Phase II (28083)
Phase III (20895)
Pipeline (452)
Postmarket research (2766)
Preclinical (8576)
Radiopharmaceuticals (247)
Rare diseases (229)
Real estate (6291)
Regulatory (21419)
Research institute (2524)
Resumes & cover letters (460)
Southern California (1237)
Startups (3499)
United States (12886)
Vaccines (578)
Weight loss (180)
Date
Today (1)
Last 7 days (666)
Last 30 days (3487)
Last 365 days (34729)
2024 (31867)
2023 (38730)
2022 (49496)
2021 (54624)
2020 (53639)
2019 (47444)
2018 (36010)
2017 (32984)
2016 (32808)
2015 (38413)
2014 (32114)
2013 (28446)
2012 (29712)
2011 (29558)
2010 (28292)
Location
Africa (972)
Arizona (149)
Asia (40488)
Australia (7158)
California (3091)
Canada (1241)
China (253)
Colorado (146)
Connecticut (156)
Europe (93399)
Florida (447)
Georgia (118)
Illinois (360)
Indiana (191)
Kansas (93)
Maryland (566)
Massachusetts (2375)
Michigan (160)
Minnesota (251)
New Jersey (944)
New York (939)
North Carolina (746)
Northern California (1396)
Ohio (135)
Pennsylvania (786)
South America (1311)
Southern California (1237)
Texas (447)
Utah (93)
Washington State (343)
690,995 Results for "institute of bioengineering and nanotechnology".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Pharm Country
Cell BioEngines to Present at the 2024 BIO CEO & Investor Conference
Cell BioEngines, Inc. announced that Dr. Ajay Vishwakarma, Founder and CEO of Cell BioEngines, will be presenting at the BIO CEO & Investor Conference at 2:00 p.m. EST on Monday, February 26, 2024.
February 8, 2024
·
2 min read
DNA Nanotechnology Market Expected to Grow at a CAGR of 24.67% from 2024 to 2031
Global DNA Nanotechnology Market is valued at US$ 4.34 Bn in 2023, and it is expected to reach US$ 24.29 Bn by 2031, with a CAGR of 24.67% during the forecast period of 2024-2031.
April 22, 2024
·
4 min read
Press Releases
Nanocarry Therapeutics’ Brain Penetrating Nanoplatform Selected by the NCI Nanotechnology Characterization Laboratory for its Preclinical Characterization Program
September 5, 2024
·
3 min read
BioCapital
Pantheon Vision Secures a Second Tranche of $1.8 Million to Advance Bioengineered Corneal Implants
Pantheon Vision Secures a Second Tranche of $1.8 Million to Advance Bioengineered Corneal Implants.
April 2, 2024
·
2 min read
Immutep successfully completes institutional placement and institutional component of entitlement offer
Immutep Limited ACN 009 237 889 is pleased to announce the successful completion of its institutional placement and the institutional component of its 1 for 16 pro rata accelerated non-renounceable entitlement offer of new fully paid ordinary shares in Immutep.
June 5, 2024
·
7 min read
Press Releases
CancerVax Taps Flashpoint Therapeutics’ Nanotechnology Platform to Drive Universal Cancer Treatment
August 29, 2024
·
4 min read
Biotech Beach
AMDI Receives a $5.3M NIH RADx® Tech Award to Finalize Development of Its 10 Minute RT-PCR Point-of-Care System and Respiratory Panel
Autonomous Medical Devices Incorporated has received a National Institutes of Health RADx Tech award from the National Institute of Biomedical Imaging and Bioengineering, part of the NIH.
February 28, 2024
·
2 min read
Pharm Country
SOSV-backed Biotech Firm Cell BioEngines Decides New York Is the Place to BeCell BioEngines, Inc moves to Manhattan, New York, to leverage the city’s focus and strategic investment in biotech
Cell BioEngines, Inc., founded by visionary Dr. Ajay Vishwakarma aiming to turn cancer into a curable disease announced that the SOSV-backed company will establish its executive headquarters in NYC, a hub for the fast-growing life-science ecosystem across New York state.
January 13, 2024
·
2 min read
Pharm Country
Cell BioEngines Enters Agreement with Miltenyi Bioindustry to Manufacture Hematopoietic Cell Therapy Clinical Program
Cell BioEngines, Inc. announced an agreement with Miltenyi to develop and manufacture its expanded hematopoietic stem cell transplantation product for clinical use in hematology-oncology.
December 29, 2023
·
3 min read
Business
Dr. Patrice Matchaba Appointed as Chief Executive Officer of the Bill & Melinda Gates Medical Research Institute
The Bill & Melinda Gates Medical Research Institute announced the appointment of Patrice Matchaba, MD, as Chief Executive Officer, starting June 10, 2024.
May 28, 2024
·
3 min read
1 of 69,100
Next
